Over the past 5 years, Dr. Chong Hyun Suh, a neuroradiologist at ASAN Medical Center, has utilised VUNO Med®-DeepBrain® to diagnose and monitor dementia patients. He says VUNO Med®-DeepBrain® is primarily used in medical settings because it quantifies and displays subtle atrophies that are difficult to confirm with the human eye.
Challenge
The complexities and subtleties of different dementia types necessitate a more sophisticated approach to ensure patients receive the correct diagnosis and appropriate care.
The diagnosis of dementia is a complex and challenging task due to the vast number of different types of dementia that exist. Clinicians often rely on visual assessments of brain scans to make their diagnoses, but this method has significant limitations. For instance, a doctor might observe atrophy in the hippocampus, a region commonly associated with Alzheimer’s disease. However, upon further investigation, it might turn out that the patient does not have Alzheimer’s but another form of dementia entirely. This discrepancy highlights a critical issue in the diagnostic process.
This scenario is not unique. Many types of dementia share overlapping symptoms and similar patterns of brain atrophy, making it difficult to distinguish between them based solely on visual inspection of brain scans. This diagnostic ambiguity can lead to misdiagnosis, delaying appropriate treatment and potentially causing significant distress for patients and their families.
Solution
VUNO Med®-DeepBrain® offers several significant benefits, particularly in enhancing the accuracy and objectivity of diagnoses through the precise information it provides.
“The normative percentile scores were a game-changer. They allowed me to see patients’ brain structure deviated from the norm with clear, quantifiable metrics. This objective data eliminated much of the subjectivity that typically accompanies visual assessments. The detailed analysis of various brain regions, automated by the deep learning algorithms, revealed subtle changes that I might have overlooked otherwise.
The comprehensive reports generated by VUNO Med®-DeepBrain® were another highlight. They provided clear visualizations and detailed quantitative data, which were not only easy for me to interpret but also helpful in explaining the situation to patients and their family. This transparency fostered a better understanding and trust in the treatment plan”
– Dr. Suh
When faced with complex and confusing cases, Dr. Suh uses VUNO Med®-DeepBrain® to identify accurate and subtle atrophic changes. These are aspects that would be difficult to detect without this solution.
About ASAN Medical Center
Since its establishment in June 1989, Asan Medical Center has achieved its status as a world-class, patient-centered medical institution through generous investment in clinical treatment and R&D. Asan Medical Center is leading the medical development of Korea with competitive medical skills and cutting-edge technology, comparable to other world leading hospitals.
